Q2 2021

Filed Aug 18, 2021 · 10-Q · 49 days after period end · 0001104659-21-107102

Q2 2021 · 10-Q

Revenue—

Net Income

$371.14K

no prior Q2 2020 on file

EPS, diluted—

Operating Income-$1,071,142—

Operating Cash Flowderived-$405,324—

Same quarter

no prior Q2 2020 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2021 · filed Aug 18, 2021 · 49 d after period end

Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR